Deskside: COVID-19, Vaping, and Teens: A Dangerous Mix

Cynthia J. Brandt, PhD, President and CEO
Wednesday, July 29, 2020

Yesterday, we launched a new suite of online events: The Deskside Series. Designed to give you access to some of the best and brightest minds at Stanford University School of Medicine, these 45-minute sessions will feature a moderated presentation and Q&A. In our inaugural Deskside, I sat down (virtually) with Bonnie Halpern-Felsher, PhD to discuss COVID-19, vaping, and teens.

We know for a fact that vaping is risky to developing brains. We know it correlates with future cigarette and drug use. And yet, vaping among teens is still on the rise. More than 1 in 4 high school students use e-cigarettes. That's almost three times as many as just two years ago. COVID-19 is raising the stakes for vaping, but we have a plan to wipe it out.

During the Deskside, we introduced 17-year-old Luka from North Carolina. I can’t stop thinking about his story—being offered an e-cigarette and being told it was just vegetable oil and water. It drives home how vital Dr. Bonnie Halpern-Felsher’s research and anti-vaping advocacy work are for young people in our community and beyond. The impact we make today can save teens’ lives, especially as we face COVID-19 and the added risks for vape users. Are you ready to dive in?

  • Watch and share the webinar recording.

Thank you again for joining us as we embark on this new Deskside series, learning together how we can ensure our children and young people have healthier futures.

HOW YOU CAN HELP
Make a gift to support Dr. Bonnie Halpern-Felsher's team.
Share your story
Share your connection to Lucile Packard Children's Hospital Stanford.